Significantly, shRNA-mediated stable knockdown of Gab1 inhibited NLGN3-induced Akt, Erk1/2 and S6K phosphorylation in U251 and primary glioma cells (Figure 4A and B). Here, MAPK3 is linked to central nervous system cancer.